In Vivo CRISPR Screening Platform for Studying Myeloid Inflammation and Clonal Dynamics

被引：0
|
作者：
Kim, Peter Geon [1 ]
Hergott, Christopher B. [1 ]
Loke, Justin C. T. [1 ]
Shin, Wesley [1 ]
McConkey, Marie E. [1 ]
Ebert, Benjamin L. [2 ,3 ,4 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Broad Inst MIT & Harvard Univ, Cambridge, MA USA
[3] Howard Hughes Med Inst, Boston, MA USA
[4] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-188939
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML
    Lin, Shan
    Larrue, Clement
    Scheidegger, Nastassja K.
    Seong, Bo Kyung A.
    Dharia, Neekesh, V
    Kuljanin, Miljan
    Wechsler, Caroline S.
    Kugener, Guillaume
    Robichaud, Amanda L.
    Conway, Amy Saur
    Mashaka, Thelma
    Mouche, Sarah
    Adane, Biniam
    Ryan, Jeremy A.
    Mancias, Joseph D.
    Younger, Scott T.
    Piccioni, Federica
    Lee, Lynn H.
    Wunderlich, Mark
    Letai, Anthony
    Tamburini, Jerome
    Stegmaier, Kimberly
    CANCER DISCOVERY, 2022, 12 (02) : 432 - 449
  • [2] An In Vivo CRISPR Screening Platform to Identify New Therapeutic Targets in AML
    Lin, Shan
    Larrue, Clement
    Scheidegger, Natassja K.
    Seong, Bo Kyung A.
    Dharia, Neekesh V.
    Wechsler, Caroline
    Kugener, Guillaume
    Robinchaud, Amanda L.
    Conway, Amy
    Adane, Biniam
    Younger, Scott
    Piccioni, Federica
    Lee, Lynn
    Wunderlich, Mark
    Tamburini, Jerome
    Stegmaier, Kimberly
    BLOOD, 2021, 138
  • [3] Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications
    Elena, Chiara
    Galli, Anna
    Bono, Elisa
    Todisco, Gabriele
    Malcovati, Luca
    CURRENT OPINION IN HEMATOLOGY, 2021, 28 (05) : 347 - 355
  • [4] High-Throughput Screening Platform of Lipid Nanoparticles for In Vivo CRISPR/Cas Gene Editing
    Xia, Qing
    Wang, Bang
    Yang, Chengbiao
    Zheng, Zongli
    MOLECULAR THERAPY, 2023, 31 (04) : 281 - 281
  • [5] An In Vivo CRISPR Screening Platform to Evaluate the Therapeutic Impact of DNA Damage Response Gene Mutations
    Wang, Q.
    Simpson, D. A.
    Gupta, G. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E504 - E505
  • [6] High-throughput screening platform for CRISPR
    Winkless, Laurie
    MATERIALS TODAY, 2016, 19 (03) : 132 - 132
  • [7] In vivo Stem Cell Clonal Dynamics
    Camargo, Fernando D.
    BLOOD, 2015, 126 (23)
  • [8] In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies
    Mercier, Francois E.
    Shi, Jiantao
    Sykes, David B.
    Oki, Toshihiko
    Jankovic, Maja
    Man, Cheuk Him
    Kfoury, Youmna S.
    Miller, Elizabeth
    He, Shutao
    Zhu, Alexander
    Vasic, Radovan
    Doench, John
    Orthwein, Alexandre
    Michor, Franziska
    Scadden, David T.
    BLOOD ADVANCES, 2022, 6 (17) : 5072 - 5084
  • [9] An efficient, non-viral arrayed CRISPR screening platform for iPSC-derived myeloid and microglia models
    Meier, Sonja
    Larsen, Anne Sofie Gry
    Wanke, Florian
    Mercado, Nicolas
    Mei, Arianna
    Takacs, Livia
    Mracsko, Eva Suszanna
    Collin, Ludovic
    Kampmann, Martin
    Roudnicky, Filip
    Jagasia, Ravi
    STEM CELL REPORTS, 2025, 20 (03):
  • [10] Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia
    Tanaka, Tomoyuki
    Morita, Kiyomi
    Loghavi, Sanam
    Wang, Feng
    Furudate, Ken
    Sasaki, Yuya
    Little, Latasha
    Gumbs, Curtis
    Matthews, Jairo
    Daver, Naval
    Pemmaraju, Naveen
    DiNardo, Courtney D.
    Sasaki, Koji
    Yilmaz, Musa
    Kadia, Tapan M.
    Ravandi, Farhad
    Konopleva, Marina Y.
    Kantarjian, Hagop M.
    Champlin, Richard E.
    Al-Atrash, Gheath
    Garcia-Manero, Guillermo
    Wang, Sa A.
    Futreal, P. Andrew
    Takahashi, Koichi
    BLOOD, 2021, 138 (18) : 1733 - 1739
12345